KCT0001855Completed未知
The efficacy comparison of fibroblast growth factor versus pre-made human dermal matrix for the treatment of chronic vocal fold scarring or sulcus vocalis
Soon Chun Hyang University Hospital Bucheon0 sites17 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 17
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- o Limit to o Limit (—)
- Sex
- All
Inclusion Criteria
- •Based on the results of a stroboscopic examination, history of chronic vocal fold scarring of over 1 year’s duration
Exclusion Criteria
- •Patients with a history of other vocal fold diseases, such as vocal fold atrophy, vocal fold mucosal lesion, granuloma, or sulcus vocalis, or a history of malignant tumors of the vocal fold were excluded.
Investigators
Similar Trials
Recruiting
Not Applicable
Study to determine levels of Fibroblast Growth Factor 23 and other associated markers of bone turnover in men with various iron store states of iron overload, iron deficiency and normal iron stores.ACTRN12613000594729Associate Professor Emily Hibbert140
Completed
Phase 3
A Non-Inferiority Study Evaluating Fibroblast Growth Factor-2 (KCB-1D) to Enamel Matrix Derivative (Emdogain(R)Gel) for Periodontal Tissue Regeneration.patients with periodontitis who require surgical intervention (flap surgery)JPRN-UMIN000008231KAKEN PHARMACEUTICAL CO., LTD.240
Active, not recruiting
Unknown
Efficacy of nuclear medicine imaging to detect fibroblast activation protein in pancreatic and biliary tract cancer.NeoplasmsKCT0009207Seoul National University Hospital30
Recruiting
Phase 1
Clinical study on fibroblast growth factor administration to nasal septal perforatioJPRN-jRCTs031220604Otori Nobuyoshi10
Recruiting
Not Applicable
Prospective study of efficiency of fibrosis score in computed tomography as predictor after treatment with Nintedanib for idiopathic pulmonary fibrosisidiopathic pulmonary fibrosisJPRN-UMIN000020722Kanagawa Cardiovascular and Respiratory Center30